Assert-IQ vs Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

by Element Science, Inc.

AI Verdict

Assert-IQ is an insertable cardiac monitor focused on long-term, continuous diagnostic monitoring and advanced arrhythmia detection for patient management. In contrast, the Jewel P-WCD is a wearable device that not only monitors heart rhythms but also provides immediate treatment for life-threatening arrhythmias. While both leverage AI for arrhythmia detection, Assert-IQ is for diagnosis and long-term insights, whereas Jewel P-WCD offers active therapeutic intervention for at-risk patients.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous diagnostic monitoring for suspected heart rhythm disorders over an extended period, up to six years. This system is ideal for identifying elusive arrhythmias that may not manifest frequently, offering comprehensive data collection and remote clinician alerts for proactive management.

View Assert-IQ →

Choose Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) if…

Choose the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) if you require a highly compliant, wearable solution that not only monitors but also provides immediate therapeutic intervention for life-threatening arrhythmias. This device is best suited for patients at high risk of sudden cardiac arrest who need continuous protection and high compliance, even during daily activities like showering.

View Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Pricing	Enterprise	Contact vendor
Deployment	Hybrid	Hardware device with associated mobile application and cloud-based digital health platform.
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

The Jewel Patch WCD offers superior day-to-day usability due to its non-invasive, water-resistant, and discreet patch design, which contributes to high patient compliance (median wear time over 23 hours/day). While Assert-IQ is minimally invasive, a wearable patch generally provides greater patient comfort and ease in daily activities.

Clinical Value

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

Both tools provide valuable continuous monitoring and arrhythmia detection. However, the Jewel Patch WCD offers a critical advantage by not only detecting but also actively *treating* specific life-threatening arrhythmias through its cardioverter defibrillator function, providing immediate therapeutic intervention.

Pricing & Value

Tie

Both Assert-IQ and Jewel Patch WCD have opaque pricing models, requiring direct contact with the vendor for institutional or specific pricing details. Neither tool offers a free trial. Without publicly available pricing or detailed cost-benefit analyses, it is impossible to definitively compare their value propositions.

Enterprise Readiness

Assert-IQ

Abbott Medical, the company behind Assert-IQ, is a global healthcare leader with a long history and extensive experience in deploying and supporting medical devices within large health systems, hospitals, and cardiology clinics. This established infrastructure and market presence provide a significant advantage in enterprise readiness compared to Element Science, Inc., a newer company.

Innovation

Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)

While Assert-IQ offers advanced long-term diagnostic capabilities, the Jewel Patch WCD demonstrates greater innovation by integrating therapeutic defibrillation into a highly compliant, water-resistant, and discreet wearable patch. This combines continuous monitoring with immediate life-saving treatment in a novel, patient-friendly form factor.

Support & Docs

Assert-IQ

Abbott Medical, as a large and long-established global company, provides a more comprehensive and mature support ecosystem, including extensive manuals for clinicians and patients, and dedicated technical support channels. Element Science also offers documentation and instructional videos, but its newer and more limited market presence suggests a less extensive global support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)
Device Type / Core Function	Insertable Cardiac Monitor (ICM) system for long-term, continuous monitoring and advanced arrhythmia detection.	Patch Wearable Cardioverter Defibrillator (P-WCD) for continuous heart monitoring and treatment of life-threatening arrhythmias.
Company	Abbott Medical	Element Science, Inc.
Mobile App Availability	None	Associated Jewel Mobile App for near real-time therapy information to medical team.
Primary Monitoring/Treatment Capability	Long-term continuous cardiac monitoring (up to 6 years) and advanced arrhythmia detection.	Continuous heart rhythm monitoring, detects and treats specific life-threatening arrhythmias.
Wearability / Insertion	Minimally invasive insertion	Patch-based wearable, water-resistant design for continuous wear, including showering.
Patient Interaction / Compliance	Patient activator for symptom logging, remote monitoring capabilities.	High patient compliance (median wear time over 23 hours/day), discreet, under-clothing design.

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel).

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in the primary function of Assert-IQ and Jewel?

Assert-IQ is an insertable cardiac monitor (ICM) focused on long-term continuous monitoring and advanced arrhythmia detection to aid in diagnosing and managing patients with suspected heart rhythm disorders. Jewel is a wearable cardioverter defibrillator (P-WCD) designed for continuous heart monitoring and the treatment of life-threatening arrhythmias.

How do the devices differ in terms of patient wearability and invasiveness?

Assert-IQ is a minimally invasive insertable device, implanted just beneath the skin in the upper chest area, providing long-term monitoring for up to six years. Jewel is a non-invasive, patch-based wearable device that is water-resistant and designed for continuous daily wear, including showering.

What is the typical duration of monitoring or use for each device?

Assert-IQ offers long-term continuous cardiac monitoring for up to 6 years. Jewel is a wearable device designed for continuous daily wear, with a reported median wear time over 23 hours per day, and can be worn for up to a week at a time.

Do both devices offer treatment capabilities for arrhythmias?

No, Assert-IQ focuses on advanced arrhythmia detection and monitoring to aid in diagnosis and management. Jewel, as a wearable cardioverter defibrillator, is designed to detect and treat specific life-threatening arrhythmias by delivering an electrical shock.

How do patients interact with each device for symptom logging or data access?

Assert-IQ includes a patient activator for symptom logging and transmits data via Bluetooth to a secure cloud-based data platform, with remote monitoring capabilities. Jewel has an associated mobile app (Jewel Mobile App) that provides near real-time therapy information to the medical team.

What kind of patient compliance can be expected with each device?

Assert-IQ is an insertable device, which inherently removes the daily compliance burden once implanted. Jewel is a wearable device designed for high patient compliance, with a reported median wear time over 23 hours per day, and its water-resistant and discreet design allows for continuous wear during daily activities.